FemPulse has recently achieved a significant milestone by obtaining an investigational device exemption (IDE) from the US Food and Drug Administration (FDA). This approval allows the company to conduct a pivotal clinical trial for its neuromodulation system designed to treat overactive bladder
December 16, 2024The recent proposal by the FDA to ban the use of electric shock devices has sparked a significant debate among autism advocates and the public. This issue is especially pronounced at the Judge Rotenberg Educational Center near Boston, where such devices have been used on students. The prolonged
December 12, 2024The launch of GE HealthCare's Venue Sprint marks a significant leap in the world of portable ultrasound technology. For years, GE HealthCare has been at the forefront of digital health solutions and medical advancements, and the Venue Sprint stands as a testament to their commitment to
October 15, 2024Route 92 Medical, a leader in neurovascular intervention, has successfully secured an additional $50 million, extending its Series F financing round to a total of $82 million. This significant capital injection aims to accelerate the company’s global commercialization of innovative medical devices d
September 26, 2024The medical device landscape for treating acute ischemic stroke is on the cusp of a major transformation with the recent conditional Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Anaconda Biomed's ANA Funnel Catheter. This key milestone
September 26, 2024Sandvik’s EXERA® medical wire represents a leap forward in the medical device industry, offering unparalleled biocompatibility, durability, and conductivity. These custom-fabricated wires are designed to transmit, sense, or stimulate signals within the body, playing a crucial role in medical de
September 18, 2024